The Technical Analyst
Select Language :
Black Diamond [BDTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Black Diamond Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Black Diamond is listed at the  Exchange

3.47% $5.07

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 262.21 mill
EPS: -1.880
P/E: -2.70
Earnings Date: May 07, 2024
SharesOutstanding: 51.72 mill
Avg Daily Volume: 0.604 mill
RATING 2024-03-28
B
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -2.70 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.46x
Company: PE -2.70 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.704
(-86.12%) $-4.37
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.66 - 5.48

( +/- 8.11%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-14 Ni Fang Buy 200 000 Stock Option (Right to Buy)
2024-02-14 Hatzis-schoch Brent Buy 200 000 Stock Option (Right to Buy)
2024-02-14 Yurasov Sergey Buy 225 000 Stock Option (Right to Buy)
2024-02-14 Buck Elizabeth Buy 200 000 Stock Option (Right to Buy)
2024-02-14 Velleca Mark A. Buy 537 000 Stock Option (Right to Buy)
INSIDER POWER
98.60
Last 99 transactions
Buy: 12 432 456 | Sell: 275 000

Forecast: 16:00 - $5.06

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $5.06
Forecast 2: 16:00 - $5.06
Forecast 3: 16:00 - $5.06
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.07 (3.47% )
Volume 0.354 mill
Avg. Vol. 0.604 mill
% of Avg. Vol 58.52 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Black Diamond Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Black Diamond Therapeutics Inc

RSI

Intraday RSI14 chart for Black Diamond Therapeutics Inc

Last 10 Buy & Sell Signals For BDTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$4.43N/AActive
Profile picture for
            Black Diamond Therapeutics Inc

BDTX

Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
TIAUSDMar 29 - 00:5514.36
LPTUSDMar 29 - 00:55$19.19
RBNUSDMar 29 - 00:541.679
NMRUSDMar 29 - 00:55$37.12
ILVUSDMar 29 - 00:55136.64
CGOUSDMar 29 - 00:5471.83
BTC2X-FLIUSDMar 29 - 00:5531.97
AVAXUSDMar 29 - 00:55$53.89
ATOMUSDMar 29 - 00:55$12.17
MKRUSDMar 29 - 00:54$3 755.47

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.